China’s Academy of Sciences has successfully launched the Three-Needle Catheter System for robotic-assisted surgery, marking a significant advancement in clinical applications. The system, developed in collaboration with Hong Kong Polytechnic University, has been introduced in a First-in-Man clinical trial.
The trial commenced on March 27, 2026, at Hong Kong Baptist Hospital, where it was implemented with the assistance of medical professionals from the Hong Kong University of Science and Technology. The aim of the trial is to evaluate the system’s effectiveness in performing a specific procedure involving the Three-Needle Catheter.
Initial evaluations indicate that the Three-Needle Catheter System has shown promising results, particularly in enhancing surgical precision and safety. The robotic system enables high-precision motion control, advanced safety protocols, and intelligent navigation technologies, ensuring stable and accurate device operation while safeguarding critical steps in the procedure.
Compared to traditional manual techniques, this robotic system can potentially reduce the physical strain on surgeons during operations, thereby improving their comfort and performance. Additionally, the system’s functionality aims to enhance the efficiency of surgical workflows, ultimately improving patient outcomes.
This clinical trial is a collaborative effort between the Chinese Academy of Sciences and several key medical institutions, emphasizing the importance of interdisciplinary cooperation in advancing surgical technologies.
As the trial progresses, it aims to establish a foundation for further developments in robotic-assisted surgical applications, contributing to the ongoing evolution of medical practices.
For more updates on this innovative technology, stay tuned.
Original article by NenPower, If reposted, please credit the source: https://nenpower.com/blog/chinas-first-in-human-application-of-domestic-robot-assisted-three-dimensional-endoscopy-system-achieved-by-the-academy-of-sciences/
